Mitochondrial + metabolic recomp blend
Mitochondrial biogenesis meets NNMT inhibition — the metabolic recomp stack.

MOTS-c is a mitochondrial derived peptide that improves insulin sensitivity and cellular energy production; 5-Amino-1MQ blocks NNMT in fat cells to restore NAD+ and SAM pools. Together they attack the two biggest drivers of stubborn body composition: sluggish mitochondria and fat cell metabolic drag.
AM dosing is best — both compounds are stimulatory. Pairs well with zone-2 cardio protocols.
Educational only · Not a vendor claim
MOTS-c is a 16-amino acid mitochondrial derived peptide that improves insulin sensitivity and mitochondrial biogenesis. 5-Amino-1MQ blocks NNMT in adipose tissue, restoring NAD+ and SAM pools inside fat cells. Together they address both cellular energy production and the metabolic drag of stubborn adipose tissue.
Educational summary · Not medical advice · Discuss with a qualified clinician
General pattern for the Mitochondrial category. Individual response varies.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Sign in to keep a private log of your doses and notes for MOTS-c + 5-Amino-1MQ Blend.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.